Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician.

Detalles Bibliográficos
Publicado en:Nature Reviews Rheumatology Vol. 20; no. 3; pp. 196 - 197
Autores principales: Szekanecz, Zoltán, Buch, Maya H., Charles-Schoeman, Christina, Galloway, James, Karpouzas, George A., Kristensen, Lars Erik, Ytterberg, Steven R., Hamar, Attila, Fleischmann, Roy
Formato: Journal Article
Publicado: Springer Nature Mar2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175753773&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 175753773
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17594790
        8UU9
      jtl: Nature Reviews Rheumatology
      issn: 17594790
      maglogo: N
    pubinfo:
      dt: Mar2024
      vid: 20
      iid: 3
      pid: 2579
      pub: Springer Nature
      place: Dordrecht, <Blank>
    artinfo:
      ui:
        175753773
        10.1038/s41584-024-01085-w
        175753773
      ppf: 196
      ppct: 1
      formats:
      tig:
        atl: Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician.
      aug:
        au:
          Szekanecz, Zoltán
          Buch, Maya H.
          Charles-Schoeman, Christina
          Galloway, James
          Karpouzas, George A.
          Kristensen, Lars Erik
          Ytterberg, Steven R.
          Hamar, Attila
          Fleischmann, Roy
        affil: https://ror.org/02xf66n48 Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Unknown
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N